SlideShare a Scribd company logo
HOW CAN WE INTEGRATE GRADE AND A FORMAL CONSENSUS
METHOD INTO AN INTERNATIONAL GUIDELINE PROJECT?
THE EXAMPLE OF AN INTERNATIONAL CONSENSUS CONFERENCE ON PATIENT BLOOD
MANAGEMENT (ICC-PBM)
HANS VAN REMOORTEL
COORDINATING RESEARCHER
CENTRE FOR EVIDENCE-BASED PRACTICE (CEBAP)
BELGIAN RED CROSS
WWW.CEBAP.ORG
Conflicts of interests
 Employee of Belgian Red Cross-Flanders, providing safe blood products
to hospitals in Flanders and Brussels which did not influence his
contribution to ICC-PBM 2018 Frankfurt
 No conflicts of interest to declare
Outline
1.Patient Blood Management: 3 topics of interest and 17
PICO questions
2. Using a formal consensus methodology: the Consensus
Development Conference
3. Using an evidence-based methodology: the GRADE approach
Patient blood management (PBM) is a patient-
focused, evidence-based and systematic
approach to optimize the management of
patient and transfusion of blood products for
quality and effective patient care.
Goodnough 2012
Scientific Committee: formulating 3 topics
of interest and 17 PICO questions
Scientific Committee
Pierre Albaladejo (Grenoble University Hospital, France/ISTH)
Shubha Allard (NHS Blood & Transplant/ISBT)
Cécile Aubron (Academic Hospital of Brest, France/SFTS)
Kari Aranko (European Blood Alliance/EBA)
Dana Devine (Canadian Blood Services/CBS)
Craig French (Western Health, Melbourne Australia)
Kathrine P. Frey (Fairview Health Services and Patient Readiness
Institute, Minneapolis MN/AABB)
Christian Gabriel (Ludwig Boltzmann Institute for clinical and
experimental traumatology, Austria/DGTI)
Richard Gammon (One Blood, Orlando/AABB)
Andreas Greinacher (Institut für Immunologie und
Transfusionsmedizin Greifswald/ICTMG)
Marian van Kraaij (Sanquin, the Netherlands/EBA)
Jerrold Levy (Duke University School of Medicine, North Carolina/ISTH)
Giancarlo Liumbruno (Italian National Institute of Health/EBA)
Patrick Meybohm (University Clinics of the Johann Wolfgang Goethe University Frankfurt/Main)
Markus Müller (Institute for Transfusion Medicine and Immunohaematology Frankfurt/EBA)
Mike Murphy (NHS Blood & Transplant and AABB/EBA)
Hans Van Remoortel (Centre for Evidence-Based Practice, Belgian Red Cross)
Ben Saxon (Australian Red Cross Blood Service/ARCBS)
Erhard Seifried (German Red Cross Blood Transfusion Services/EBA) (chair)
Nadine Shehata (Mount Sinai Hospital Toronto/ICTMG)
Pierre Tiberghien (French National Blood Service/EBA)
Claudio Velati (Società Italiana di Medicina Trasfusionale e Immunoematologia)
Erica Wood (Epidemiology and Preventive Medicine at Monash University/ISBT)
Face-to-face meeting SciCom February 2017
Topic 1: Preoperative anaemia
 Definition and diagnosis (PICO 1 and PICO 2)
 Treatment (PICO 3)
Topic 2: RBC transfusion triggers
 Intensive care and acute interventions (PICO 4-9 & PICO 14)
 Haematology and oncology (PICO 10 & PICO 11)
 Neurology (PICO 12 & PICO 13)
Topic 3: PBM implementation
 Effectiveness implementation of ‘comprehensive’ PBM programs (PICO 15)
 Effectiveness behavioural interventions (PICO 16)
 Effectiveness decision support systems (PICO 17)
Face-to-face meeting SciCom February 2017
Scientific Committee: formulating 3 topics
of interest and 17 PICO questions
Scientific Committee
Outline
1. Patient Blood Management: 3 topics of interest and 17 PICO
questions
2.Using a formal consensus methodology: the Consensus
Development Conference
3. Using an evidence-based methodology: the GRADE approach
2-day International Consensus Conference on Patient Blood
Management
(24 & 25 April, Frankfurt, Germany)
- 200 medical experts
- From 5 continents
- Representing more than 10
disciplines (e.g. transfusion
medicine, surgery,
anesthesiology and
haematology)
- Co-sponsors: AABB, ISBT,
DGTI, SFTS, SIMTI, EBA
- Participation: ARCBS, TBS,
ICTMG, ISTH, NBA, ÖGBT,
SFAR
- Presence: WHO, EU
Commission, DGAI, National
Health Authority Australia
Scientific Committee
Decision-
making
panelists
Speakers
(Co-)chairs
Audience
Rapporteurs
Consensus Development Conference (CDC)
Consensus Development Conference (CDC)
*Nair R et al., Semin Arthritis Rheum, 2011; Sher G and Devine D, Transfusion, 2007
Major steps in the Consensus Development Conference format?
1) Evidence presented by the SCIENTIFIC COMMITTEE to the conference,
CHAIRED in a public (open) session followed by discussion (AUDIENCE)
2) Private (executive) session by DECISION-MAKING panel to further deliberate
on the evidence and discussion to reach consensus -> result: draft
consensus statement.
3) Presentation of draft consensus statement in a plenary session +
review/comment/indicative voting by conference attendees.
4) Final executive session with final consensus statement by DECISION-
MAKING PANEL.
Outline
1. Patient Blood Management: 3 topics of interest and 17 PICO
questions
2. Using a formal consensus methodology: the Consensus
Development Conference
3.Using an evidence-based methodology: the GRADE
approach
GRADE approach
From evidence to recommendations – transparent and sensible
P
I
C
O
Outcome
Outcome
Outcome
Outcome
Critical
Critical
Important
Not
High
Moderate
Low
Very low
GradedownGradeup
1. Risk of bias
2. Inconsistency
3. Indirectness
4. Imprecision
5. Publication
bias
1. Large effect
2. Dose
response
3. Confounders
Summary of findings
& estimate of effect
for each outcome
Systematic review
Randomization
Experimental: High
Observational: Low
Scientific Committee
GRADE
overall quality of the evidence
across outcomes based on
lowest quality
of critical outcomes
Guideline development
GRADE recommendations
Evidence to recommendation
• For or against (direction) ↑↓
• Strong or conditional/weak
(strength)
By considering balance of consequences
(evidence to recommendation)
 Quality of evidence
 Balance benefits/harms
 Values and preferences
 Resource use (cost(-effectiveness)
 Equity – Acceptability - Feasibility
• “We recommend using…”
• “We recommend against using…”
• “We suggest using…”
• “We suggest against using…”
EtD framework
GRADEpro Guideline Formulate recommendations
Transparency, clear, actionable
Research?
Decision-making
panelists
Audience
Rapporteurs
(Co-)chairs
Panelists
GRADE approach
From evidence to recommendations – transparent and sensible
CRITERIA JUDGEMENT
RESEARCH
EVIDENCE
ADDITIONAL CONSIDERATIONS
1. DESIRABLE EFFECTS How substantial are the desirable anticipated effects?
2. UNDESIRABLE EFFECTS How substantial are the undesirable anticipated effects?
3. CERTAINTY OF EVIDENCE What is the overall quality of the evidence of effects?
4. VALUES
Is there important uncertainty about or variability in how
much people value the critical outcomes?
5. BALANCE OF EFFECTS
Does the balance between desirable and undesirable
effects favor the intervention or the comparison?
6. RESOURCES REQUIRED How large are the resource requirements (costs)?
7. COST EFFECTIVENESS
Does the cost-effectiveness of the intervention favor the
intervention or the comparison?
8. EQUITY What would be the impact on health equity?
9. ACCEPTABILITY Is the intervention acceptable to key stakeholders?
10. FEASIBILITY Is the intervention feasible to implement?
Evidence-to-Decision framework
Rapporteurs
Rapporteurs
Rapporteurs
Rapporteurs
Rapporteurs
Rapporteurs
Rapporteurs
Rapporteurs
Rapporteurs
Rapporteurs
Audience
Audience
Audience
Audience
Audience
Audience
Audience
Audience
Audience
Audience
Outline
1. Patient Blood Management: 3 topics of interest and 17 PICO
questions
2.Using a formal consensus methodology: the Consensus
Development Conference
3.Using an evidence-based methodology: the GRADE
approach
+
1 year of preparation
• Feb 2017: SciCom meeting,
Frankfurt (Germany)
• June 2017: Sponsors meeting,
ISBT Copenhagen (Denmark)
• March 2017 – April 2018:
12 SciCom teleconferences
• Jan/Feb 2018: two face-to-face
meetings with SciSec and chairs,
Frankfurt (Germany)
• March 2017 – January 2018:
systematic reviews 17 PICO
questions (+/- 18.000 references
screened, 145 studies included)
• Dec 2017 – April 2018:
• 2 SciCom webinars
• 4 panellists webinars
• 3 chairs webinars
• 1 webinar rapporteurs
• 1 tutorial rapporteurs
• 2 speakers webinars
Start day 1 (24 April 2018)
3 Parallel sessions
Session 1: Preoperative anaemia
 Definition and diagnosis
(PICO 1 and PICO 2)
 Treatment
(PICO 3)
Session 2: RBC transfusion triggers
 Intensive care and acute interventions
(PICO 4-9 & PICO 14)
 Haematology and oncology
(PICO 10 & PICO 11)
 Neurology
(PICO 12 & PICO 13)
Session 3: PBM implementation
 Effectiveness implementation of
‘comprehensive’ PBM programs
(PICO 15)
 Effectiveness behavioural interventions
(PICO 16)
 Effectiveness decision support systems
(PICO 17)
Day 1 (24 April 2018)
Part 1: Plenary
• Evidence presented by
• Based on Evidence-to-Decision (EtD) framework
• Discussion with
moderated by
• Notes recorded by
AudienceRapporteurs
(Co-)chairs Panelists
Speakers
Day 1: 3 parallel/open sessions
Day 1: 3 parallel/open sessions
3 Parallel sessions
Session 1: Preoperative anaemia
 Definition and diagnosis
(PICO 1 and PICO 2)
 Treatment
(PICO 3)
Session 2: RBC transfusion triggers
 Intensive care and acute interventions
(PICO 4-9 & PICO 14)
 Haematology and oncology
(PICO 10 & PICO 11)
 Neurology
(PICO 12 & PICO 13)
Session 3: PBM implementation
 Effectiveness implementation of
‘comprehensive’ PBM programs
(PICO 15)
 Effectiveness behavioural interventions
(PICO 16)
 Effectiveness decision support systems
(PICO 17)
Day 1 (24 April 2018)
+
+
+
Part 1: Plenary
Part 2: Closed (private/executive session)
• Evidence presented by
• Based on Evidence-to-Decision (EtD) framework
• Discussion with
moderated by
• Notes recorded by
• Based on EtD framework
• Draft recommendations
by
• Moderated by
• Notes recorded by
AudienceRapporteurs
(Co-)chairs Panelists
Speakers
Day 1: closed session with decision-making panels
Draft conclusions at the end of day 1
TYPE OF
RECOMMENDATION
Strong recommendation
against the intervention
Conditional recommendation
against the intervention
Conditional recommendation
for either the intervention or
the comparison
Conditional recommendation
for the intervention
Strong recommendation for
the intervention
RECOMMENDATION Option 1: Formulation of a strong or conditional recommendation
Terminology strong recommendation: “we recommend…” – “clinicians should…” – “clinicians shoud not….” – “Do….” – “Don’t…..”
Terminology weak/conditional recommendation: “we suggest…” – “clinicians might….” – “we conditionally recommend…”
Option 2: No recommendation
Option 3: Research recommendation
JUSTIFICATION
…
SUBGROUP
CONSIDERATIONS …
IMPLEMENTATION
CONSIDERATIONS …
MONITORING AND
EVALUATION …
RESEARCH PRIORITIES
…
Closed session with chairs/decision-making panels/rapporteurs
 Plenary session with the general audience (all 3 topics)
 Presentation draft recommendations/justifications by
AudienceRapporteurs
(Co-)chairs Panelists
Day 2 (25 April 2018)
 Plenary session with the general audience (all 3 topics)
 Presentation draft recommendations/justifications by
 Discussion with/indicative voting by , moderated by the
 Notes recorded by
AudienceRapporteurs
(Co-)chairs Panelists
Day 2 (25 April 2018)
 Plenary session with the general audience (all 3 topics)
 Presentation draft recommendations/justifications by
 Discussion with/indicative voting by , moderated by the
 Notes recorded by
 Closed sessions with the decision-making panelists and (co-)
chairs
 Formulation of final recommendations by , moderated by the
AudienceRapporteurs
(Co-)chairs Panelists
Day 2 (25 April 2018)
Day 2: closed session with decision-making panels
Conclusions: 10 evidence-based recommendations
 Topic 1: Preoperative anaemia
 4 recommendations (1 strong, 3 conditional)
 Topic 2: RBC transfusion triggers
 4 recommendations (2 strong, 2 conditional)
 Topic 3: PBM implementation
 2 recommendations (2 conditional)
 Research recommendations for all topics
Lessons learned to improve a future
guideline project
 Preparation: time versus resources
 2 face-to-face meetings between methodologists and experts
 Beginning: PICO + selection criteria (lumping vs splitting!)
 Intermediate: to discuss results systematic review
 Improve sense of ownership and knowledge of evidence-based methodology by
different groups (panel members, chairs)
 More rigorous process to select panel members (COI!) and formal/blind voting system
on draft/final recommendations
 Organization Consensus conference immediately before/after blood transfusion
conference (e.g. ISBT) could increase participation (by general audience).
Acknowledgments
Prof. Dr. Erhard Seifried (German Red Cross Blood Transfusion
Services/EBA) (chair)
Dr. Kari Aranko (European Blood Alliance/EBA)
Willemijn Kramer (European Blood Alliance/EBA)
Dr. Markus Müller (Institute for Transfusion Medicine and
Immunohaematology Frankfurt/EBA)
Prof. Dr. Patrick Meybohm (University Clinics of the Johann
Wolfgang Goethe University Frankfurt/Main)
Chairs of the Plenary Sessions:
Prof. Dr. Reinhard Burger, Robert-Koch-Institute, Berlin, Germany
Prof. Dr. Klaus Cichutek, Paul-Ehrlich-Institute, Langen, Germany
Prof. Dr. Jimmy Volmink, Faculty of Medicine and Health Sciences at
Stellenbosch University, South Africa
Decision-making panel ‘Preoperative anaemia’
Prof. Dr. Yves Ozier, University Hospital of Brest, France (Chair)
Prof Dr. Emmy De Buck, Centre for Evidence Based Practice, Belgian Red
Cross-Flanders, Belgium (Co-Chair)
Decision-making panel ‘RBC transfusion triggers’
Prof. Dr. Reinhard Burger, Robert-Koch-Institute, Berlin, Germany (Chair)
Prof. Dr. Jimmy Volmink, Faculty of Medicine and Health Sciences at
Stellenbosch University, South Africa (Co-Chair)
Decision-making panel ‘PBM implementation’
Prof. Dr. Jonathan Waters, Magee-Womens Hospital of the University of
Pittsburgh Medical Center (Chair)
Prof. Dr. Dean Fergusson, Ottawa Hospital Research Institute, University of
Ottawa, Canada (Co-Chair)
Stefan Holtzem (Photographer)
Acknowledgments
Centre for Evidence-Based Practice (CEBaP)
Belgian Red Cross
www.cebap.org
@CEBaP_evidence

More Related Content

What's hot

REG Annual General Meeting 2015
REG Annual General Meeting 2015REG Annual General Meeting 2015
REG Annual General Meeting 2015
Zoe Mitchell
 
Medinfo2017 Trillium II Workshop
Medinfo2017 Trillium II WorkshopMedinfo2017 Trillium II Workshop
Towards Evidence-Based Clinical Practice Guidelines Implementation for Physic...
Towards Evidence-Based Clinical Practice Guidelines Implementation for Physic...Towards Evidence-Based Clinical Practice Guidelines Implementation for Physic...
Towards Evidence-Based Clinical Practice Guidelines Implementation for Physic...
Yasser Sami Abdel Dayem Amer
 
MCDA to elicit stakeholders' preferences in Italy. The Case of Obinutuzuma.b
MCDA to elicit stakeholders' preferences in Italy. The Case of Obinutuzuma.b MCDA to elicit stakeholders' preferences in Italy. The Case of Obinutuzuma.b
MCDA to elicit stakeholders' preferences in Italy. The Case of Obinutuzuma.b
Office of Health Economics
 
Multifactorial Approach in Clinical Research Concept and Practice in Hungary
Multifactorial Approach in Clinical Research Concept and Practice in HungaryMultifactorial Approach in Clinical Research Concept and Practice in Hungary
Multifactorial Approach in Clinical Research Concept and Practice in Hungary
Tristan Azbej, PhD
 
Company presentation
Company presentationCompany presentation
Company presentation
soneerad
 
IPF/ILD Working Group ERS 2017
IPF/ILD Working Group ERS 2017IPF/ILD Working Group ERS 2017
IPF/ILD Working Group ERS 2017
Kathryn Brown
 
Embolism
EmbolismEmbolism
Embolism
MedicinaIngles
 
The Danish Experiences in Developing and Using National Quality Registries
The Danish Experiences in Developing and Using National Quality RegistriesThe Danish Experiences in Developing and Using National Quality Registries
The Danish Experiences in Developing and Using National Quality Registries
THL
 
REG-EAACI Taskforce Report
REG-EAACI Taskforce ReportREG-EAACI Taskforce Report
REG-EAACI Taskforce Report
Zoe Mitchell
 
CAPHRI_ERC_Report 2004-2009
CAPHRI_ERC_Report 2004-2009CAPHRI_ERC_Report 2004-2009
CAPHRI_ERC_Report 2004-2009
Petra Uittenbogaard
 
Better late than never
Better late than neverBetter late than never
Better late than never
drucsamal
 
Towards a Value Framework for Antibiotics
Towards a Value Framework for AntibioticsTowards a Value Framework for Antibiotics
Towards a Value Framework for Antibiotics
Office of Health Economics
 
REG Technologies Working Group Meeting 26/09/15
REG Technologies Working Group Meeting 26/09/15REG Technologies Working Group Meeting 26/09/15
REG Technologies Working Group Meeting 26/09/15
Zoe Mitchell
 
Developing a value set for the EQ-5D-Y to support its use in HTA
Developing a value set for the EQ-5D-Y to support its use in HTADeveloping a value set for the EQ-5D-Y to support its use in HTA
Developing a value set for the EQ-5D-Y to support its use in HTA
Office of Health Economics
 
The Epidemiologist's Dream: Denmark
The Epidemiologist's Dream: DenmarkThe Epidemiologist's Dream: Denmark
The Epidemiologist's Dream: Denmark
Zoe Mitchell
 
Does society wish to prioritise end-of-life treatments over other types of tr...
Does society wish to prioritise end-of-life treatments over other types of tr...Does society wish to prioritise end-of-life treatments over other types of tr...
Does society wish to prioritise end-of-life treatments over other types of tr...
Office of Health Economics
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
Workgroup of European Cancer Patient Advocacy Networks
 
PROMISE ethics panel final report, October 17, 2012
PROMISE ethics panel final report, October 17, 2012PROMISE ethics panel final report, October 17, 2012
PROMISE ethics panel final report, October 17, 2012
erikanature
 
Audio video consenting process and role of CRC or PI during av consenting
Audio video consenting process and role of CRC or PI during av consentingAudio video consenting process and role of CRC or PI during av consenting
Audio video consenting process and role of CRC or PI during av consenting
Jagriti Bansal
 

What's hot (20)

REG Annual General Meeting 2015
REG Annual General Meeting 2015REG Annual General Meeting 2015
REG Annual General Meeting 2015
 
Medinfo2017 Trillium II Workshop
Medinfo2017 Trillium II WorkshopMedinfo2017 Trillium II Workshop
Medinfo2017 Trillium II Workshop
 
Towards Evidence-Based Clinical Practice Guidelines Implementation for Physic...
Towards Evidence-Based Clinical Practice Guidelines Implementation for Physic...Towards Evidence-Based Clinical Practice Guidelines Implementation for Physic...
Towards Evidence-Based Clinical Practice Guidelines Implementation for Physic...
 
MCDA to elicit stakeholders' preferences in Italy. The Case of Obinutuzuma.b
MCDA to elicit stakeholders' preferences in Italy. The Case of Obinutuzuma.b MCDA to elicit stakeholders' preferences in Italy. The Case of Obinutuzuma.b
MCDA to elicit stakeholders' preferences in Italy. The Case of Obinutuzuma.b
 
Multifactorial Approach in Clinical Research Concept and Practice in Hungary
Multifactorial Approach in Clinical Research Concept and Practice in HungaryMultifactorial Approach in Clinical Research Concept and Practice in Hungary
Multifactorial Approach in Clinical Research Concept and Practice in Hungary
 
Company presentation
Company presentationCompany presentation
Company presentation
 
IPF/ILD Working Group ERS 2017
IPF/ILD Working Group ERS 2017IPF/ILD Working Group ERS 2017
IPF/ILD Working Group ERS 2017
 
Embolism
EmbolismEmbolism
Embolism
 
The Danish Experiences in Developing and Using National Quality Registries
The Danish Experiences in Developing and Using National Quality RegistriesThe Danish Experiences in Developing and Using National Quality Registries
The Danish Experiences in Developing and Using National Quality Registries
 
REG-EAACI Taskforce Report
REG-EAACI Taskforce ReportREG-EAACI Taskforce Report
REG-EAACI Taskforce Report
 
CAPHRI_ERC_Report 2004-2009
CAPHRI_ERC_Report 2004-2009CAPHRI_ERC_Report 2004-2009
CAPHRI_ERC_Report 2004-2009
 
Better late than never
Better late than neverBetter late than never
Better late than never
 
Towards a Value Framework for Antibiotics
Towards a Value Framework for AntibioticsTowards a Value Framework for Antibiotics
Towards a Value Framework for Antibiotics
 
REG Technologies Working Group Meeting 26/09/15
REG Technologies Working Group Meeting 26/09/15REG Technologies Working Group Meeting 26/09/15
REG Technologies Working Group Meeting 26/09/15
 
Developing a value set for the EQ-5D-Y to support its use in HTA
Developing a value set for the EQ-5D-Y to support its use in HTADeveloping a value set for the EQ-5D-Y to support its use in HTA
Developing a value set for the EQ-5D-Y to support its use in HTA
 
The Epidemiologist's Dream: Denmark
The Epidemiologist's Dream: DenmarkThe Epidemiologist's Dream: Denmark
The Epidemiologist's Dream: Denmark
 
Does society wish to prioritise end-of-life treatments over other types of tr...
Does society wish to prioritise end-of-life treatments over other types of tr...Does society wish to prioritise end-of-life treatments over other types of tr...
Does society wish to prioritise end-of-life treatments over other types of tr...
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
 
PROMISE ethics panel final report, October 17, 2012
PROMISE ethics panel final report, October 17, 2012PROMISE ethics panel final report, October 17, 2012
PROMISE ethics panel final report, October 17, 2012
 
Audio video consenting process and role of CRC or PI during av consenting
Audio video consenting process and role of CRC or PI during av consentingAudio video consenting process and role of CRC or PI during av consenting
Audio video consenting process and role of CRC or PI during av consenting
 

Similar to Oral presentation ICC-PBM 2018 @ G-I-N conference Manchester (UK) 2018

Draft CPG Haemophilia.pdf
Draft CPG Haemophilia.pdfDraft CPG Haemophilia.pdf
Draft CPG Haemophilia.pdf
MehekBatra2
 
Presentation_Thesis defense _Thi Ha VO. 16.12.2015
Presentation_Thesis defense _Thi Ha VO. 16.12.2015Presentation_Thesis defense _Thi Ha VO. 16.12.2015
Presentation_Thesis defense _Thi Ha VO. 16.12.2015
HA VO THI
 
European clinical practice guideline on diagnosis hiponatremia
European clinical practice guideline on diagnosis hiponatremiaEuropean clinical practice guideline on diagnosis hiponatremia
European clinical practice guideline on diagnosis hiponatremia
Jaime dehais
 
Databases and Coding Validation Working Group Meeting
Databases and Coding Validation Working Group MeetingDatabases and Coding Validation Working Group Meeting
Databases and Coding Validation Working Group Meeting
Zoe Mitchell
 
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)
Swathi P
 
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo HauptPanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
KylieOBrien10
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical Research
Market iT
 
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGYEvidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
Yasser Sami Abdel Dayem Amer
 
NIHR Research Design Service
NIHR Research Design ServiceNIHR Research Design Service
NIHR Research Design Service
Azeem Majeed
 
EBP in Belgian Red Cross
EBP in Belgian Red CrossEBP in Belgian Red Cross
EBP in Belgian Red Cross
Hans Van Remoortel
 
Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015 Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015
MedicReS
 
Patient involvement
Patient involvementPatient involvement
Patient involvement
EURORDIS Rare Diseases Europe
 
Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
  Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...  Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
HIMSS UK
 
The Eumusc.net project
The Eumusc.net projectThe Eumusc.net project
The Eumusc.net project
Loreto Carmona Ortells
 
Edith Frénoy, 2nd Health Innovation Conference
Edith Frénoy, 2nd Health Innovation ConferenceEdith Frénoy, 2nd Health Innovation Conference
Edith Frénoy, 2nd Health Innovation Conference
Starttech Ventures
 
acute-appendicitis-guidelines.pdf
acute-appendicitis-guidelines.pdfacute-appendicitis-guidelines.pdf
acute-appendicitis-guidelines.pdf
EliasEmmanuelJaime
 
European Clinical Research Infrastructure Network
European Clinical Research Infrastructure NetworkEuropean Clinical Research Infrastructure Network
European Clinical Research Infrastructure Network
EURORDIS Rare Diseases Europe
 
The Surgical Safety Checklist; Rhetoric….or are we making a difference?
The Surgical Safety Checklist; Rhetoric….or are we making a difference?The Surgical Safety Checklist; Rhetoric….or are we making a difference?
The Surgical Safety Checklist; Rhetoric….or are we making a difference?
Canadian Patient Safety Institute
 
Best practice-antiseptic-antimicrobial
Best practice-antiseptic-antimicrobialBest practice-antiseptic-antimicrobial
Best practice-antiseptic-antimicrobial
GNEAUPP.
 
eHealth and patient outcomes
eHealth and patient outcomeseHealth and patient outcomes
eHealth and patient outcomes
Anna Kotzeva
 

Similar to Oral presentation ICC-PBM 2018 @ G-I-N conference Manchester (UK) 2018 (20)

Draft CPG Haemophilia.pdf
Draft CPG Haemophilia.pdfDraft CPG Haemophilia.pdf
Draft CPG Haemophilia.pdf
 
Presentation_Thesis defense _Thi Ha VO. 16.12.2015
Presentation_Thesis defense _Thi Ha VO. 16.12.2015Presentation_Thesis defense _Thi Ha VO. 16.12.2015
Presentation_Thesis defense _Thi Ha VO. 16.12.2015
 
European clinical practice guideline on diagnosis hiponatremia
European clinical practice guideline on diagnosis hiponatremiaEuropean clinical practice guideline on diagnosis hiponatremia
European clinical practice guideline on diagnosis hiponatremia
 
Databases and Coding Validation Working Group Meeting
Databases and Coding Validation Working Group MeetingDatabases and Coding Validation Working Group Meeting
Databases and Coding Validation Working Group Meeting
 
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)
 
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo HauptPanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical Research
 
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGYEvidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
 
NIHR Research Design Service
NIHR Research Design ServiceNIHR Research Design Service
NIHR Research Design Service
 
EBP in Belgian Red Cross
EBP in Belgian Red CrossEBP in Belgian Red Cross
EBP in Belgian Red Cross
 
Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015 Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015
 
Patient involvement
Patient involvementPatient involvement
Patient involvement
 
Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
  Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...  Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
 
The Eumusc.net project
The Eumusc.net projectThe Eumusc.net project
The Eumusc.net project
 
Edith Frénoy, 2nd Health Innovation Conference
Edith Frénoy, 2nd Health Innovation ConferenceEdith Frénoy, 2nd Health Innovation Conference
Edith Frénoy, 2nd Health Innovation Conference
 
acute-appendicitis-guidelines.pdf
acute-appendicitis-guidelines.pdfacute-appendicitis-guidelines.pdf
acute-appendicitis-guidelines.pdf
 
European Clinical Research Infrastructure Network
European Clinical Research Infrastructure NetworkEuropean Clinical Research Infrastructure Network
European Clinical Research Infrastructure Network
 
The Surgical Safety Checklist; Rhetoric….or are we making a difference?
The Surgical Safety Checklist; Rhetoric….or are we making a difference?The Surgical Safety Checklist; Rhetoric….or are we making a difference?
The Surgical Safety Checklist; Rhetoric….or are we making a difference?
 
Best practice-antiseptic-antimicrobial
Best practice-antiseptic-antimicrobialBest practice-antiseptic-antimicrobial
Best practice-antiseptic-antimicrobial
 
eHealth and patient outcomes
eHealth and patient outcomeseHealth and patient outcomes
eHealth and patient outcomes
 

More from CEBaP_rkv

Poster Methodological expert group @G-I-N conference Manchester (UK) 2018
Poster Methodological expert group @G-I-N conference Manchester (UK) 2018Poster Methodological expert group @G-I-N conference Manchester (UK) 2018
Poster Methodological expert group @G-I-N conference Manchester (UK) 2018
CEBaP_rkv
 
GIN conference and Cochrane Colloquium 2018
GIN conference and Cochrane Colloquium 2018GIN conference and Cochrane Colloquium 2018
GIN conference and Cochrane Colloquium 2018
CEBaP_rkv
 
An evidence-based guideline to assist volunteers in working with at-risk chil...
An evidence-based guideline to assist volunteers in working with at-risk chil...An evidence-based guideline to assist volunteers in working with at-risk chil...
An evidence-based guideline to assist volunteers in working with at-risk chil...
CEBaP_rkv
 
Standard wording for formulating evidence conclusions and implications for re...
Standard wording for formulating evidence conclusions and implications for re...Standard wording for formulating evidence conclusions and implications for re...
Standard wording for formulating evidence conclusions and implications for re...
CEBaP_rkv
 
Implementation of evidence-based African First Aid Materials (AFAM) in Sub-Sa...
Implementation of evidence-based African First Aid Materials (AFAM) in Sub-Sa...Implementation of evidence-based African First Aid Materials (AFAM) in Sub-Sa...
Implementation of evidence-based African First Aid Materials (AFAM) in Sub-Sa...
CEBaP_rkv
 
Indian First Aid Guidelines
Indian First Aid GuidelinesIndian First Aid Guidelines
Indian First Aid Guidelines
CEBaP_rkv
 
Are individuals presenting with hypotension eligible as whole blood donors? A...
Are individuals presenting with hypotension eligible as whole blood donors? A...Are individuals presenting with hypotension eligible as whole blood donors? A...
Are individuals presenting with hypotension eligible as whole blood donors? A...
CEBaP_rkv
 
Poster Presentation meta-analysis bed nets (22nd Cochrane Colloquium, Hyderab...
Poster Presentation meta-analysis bed nets (22nd Cochrane Colloquium, Hyderab...Poster Presentation meta-analysis bed nets (22nd Cochrane Colloquium, Hyderab...
Poster Presentation meta-analysis bed nets (22nd Cochrane Colloquium, Hyderab...
CEBaP_rkv
 
20140905 hypotension systematic review
20140905 hypotension systematic review20140905 hypotension systematic review
20140905 hypotension systematic review
CEBaP_rkv
 
European conference on donor health & management
European conference on donor health & managementEuropean conference on donor health & management
European conference on donor health & management
CEBaP_rkv
 

More from CEBaP_rkv (10)

Poster Methodological expert group @G-I-N conference Manchester (UK) 2018
Poster Methodological expert group @G-I-N conference Manchester (UK) 2018Poster Methodological expert group @G-I-N conference Manchester (UK) 2018
Poster Methodological expert group @G-I-N conference Manchester (UK) 2018
 
GIN conference and Cochrane Colloquium 2018
GIN conference and Cochrane Colloquium 2018GIN conference and Cochrane Colloquium 2018
GIN conference and Cochrane Colloquium 2018
 
An evidence-based guideline to assist volunteers in working with at-risk chil...
An evidence-based guideline to assist volunteers in working with at-risk chil...An evidence-based guideline to assist volunteers in working with at-risk chil...
An evidence-based guideline to assist volunteers in working with at-risk chil...
 
Standard wording for formulating evidence conclusions and implications for re...
Standard wording for formulating evidence conclusions and implications for re...Standard wording for formulating evidence conclusions and implications for re...
Standard wording for formulating evidence conclusions and implications for re...
 
Implementation of evidence-based African First Aid Materials (AFAM) in Sub-Sa...
Implementation of evidence-based African First Aid Materials (AFAM) in Sub-Sa...Implementation of evidence-based African First Aid Materials (AFAM) in Sub-Sa...
Implementation of evidence-based African First Aid Materials (AFAM) in Sub-Sa...
 
Indian First Aid Guidelines
Indian First Aid GuidelinesIndian First Aid Guidelines
Indian First Aid Guidelines
 
Are individuals presenting with hypotension eligible as whole blood donors? A...
Are individuals presenting with hypotension eligible as whole blood donors? A...Are individuals presenting with hypotension eligible as whole blood donors? A...
Are individuals presenting with hypotension eligible as whole blood donors? A...
 
Poster Presentation meta-analysis bed nets (22nd Cochrane Colloquium, Hyderab...
Poster Presentation meta-analysis bed nets (22nd Cochrane Colloquium, Hyderab...Poster Presentation meta-analysis bed nets (22nd Cochrane Colloquium, Hyderab...
Poster Presentation meta-analysis bed nets (22nd Cochrane Colloquium, Hyderab...
 
20140905 hypotension systematic review
20140905 hypotension systematic review20140905 hypotension systematic review
20140905 hypotension systematic review
 
European conference on donor health & management
European conference on donor health & managementEuropean conference on donor health & management
European conference on donor health & management
 

Recently uploaded

Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Sérgio Sacani
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
RitabrataSarkar3
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
Gokturk Mehmet Dilci
 
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdfTopic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
TinyAnderson
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
RASHMI M G
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
IshaGoswami9
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
MAGOTI ERNEST
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
pablovgd
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
SSR02
 
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
Abdul Wali Khan University Mardan,kP,Pakistan
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
Sérgio Sacani
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
by6843629
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills MN
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
KrushnaDarade1
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
The debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically youngThe debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically young
Sérgio Sacani
 

Recently uploaded (20)

Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
 
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdfTopic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
 
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
The debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically youngThe debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically young
 

Oral presentation ICC-PBM 2018 @ G-I-N conference Manchester (UK) 2018

  • 1. HOW CAN WE INTEGRATE GRADE AND A FORMAL CONSENSUS METHOD INTO AN INTERNATIONAL GUIDELINE PROJECT? THE EXAMPLE OF AN INTERNATIONAL CONSENSUS CONFERENCE ON PATIENT BLOOD MANAGEMENT (ICC-PBM) HANS VAN REMOORTEL COORDINATING RESEARCHER CENTRE FOR EVIDENCE-BASED PRACTICE (CEBAP) BELGIAN RED CROSS WWW.CEBAP.ORG
  • 2. Conflicts of interests  Employee of Belgian Red Cross-Flanders, providing safe blood products to hospitals in Flanders and Brussels which did not influence his contribution to ICC-PBM 2018 Frankfurt  No conflicts of interest to declare
  • 3. Outline 1.Patient Blood Management: 3 topics of interest and 17 PICO questions 2. Using a formal consensus methodology: the Consensus Development Conference 3. Using an evidence-based methodology: the GRADE approach
  • 4. Patient blood management (PBM) is a patient- focused, evidence-based and systematic approach to optimize the management of patient and transfusion of blood products for quality and effective patient care.
  • 6. Scientific Committee: formulating 3 topics of interest and 17 PICO questions Scientific Committee Pierre Albaladejo (Grenoble University Hospital, France/ISTH) Shubha Allard (NHS Blood & Transplant/ISBT) Cécile Aubron (Academic Hospital of Brest, France/SFTS) Kari Aranko (European Blood Alliance/EBA) Dana Devine (Canadian Blood Services/CBS) Craig French (Western Health, Melbourne Australia) Kathrine P. Frey (Fairview Health Services and Patient Readiness Institute, Minneapolis MN/AABB) Christian Gabriel (Ludwig Boltzmann Institute for clinical and experimental traumatology, Austria/DGTI) Richard Gammon (One Blood, Orlando/AABB) Andreas Greinacher (Institut für Immunologie und Transfusionsmedizin Greifswald/ICTMG) Marian van Kraaij (Sanquin, the Netherlands/EBA) Jerrold Levy (Duke University School of Medicine, North Carolina/ISTH) Giancarlo Liumbruno (Italian National Institute of Health/EBA) Patrick Meybohm (University Clinics of the Johann Wolfgang Goethe University Frankfurt/Main) Markus Müller (Institute for Transfusion Medicine and Immunohaematology Frankfurt/EBA) Mike Murphy (NHS Blood & Transplant and AABB/EBA) Hans Van Remoortel (Centre for Evidence-Based Practice, Belgian Red Cross) Ben Saxon (Australian Red Cross Blood Service/ARCBS) Erhard Seifried (German Red Cross Blood Transfusion Services/EBA) (chair) Nadine Shehata (Mount Sinai Hospital Toronto/ICTMG) Pierre Tiberghien (French National Blood Service/EBA) Claudio Velati (Società Italiana di Medicina Trasfusionale e Immunoematologia) Erica Wood (Epidemiology and Preventive Medicine at Monash University/ISBT) Face-to-face meeting SciCom February 2017
  • 7. Topic 1: Preoperative anaemia  Definition and diagnosis (PICO 1 and PICO 2)  Treatment (PICO 3) Topic 2: RBC transfusion triggers  Intensive care and acute interventions (PICO 4-9 & PICO 14)  Haematology and oncology (PICO 10 & PICO 11)  Neurology (PICO 12 & PICO 13) Topic 3: PBM implementation  Effectiveness implementation of ‘comprehensive’ PBM programs (PICO 15)  Effectiveness behavioural interventions (PICO 16)  Effectiveness decision support systems (PICO 17) Face-to-face meeting SciCom February 2017 Scientific Committee: formulating 3 topics of interest and 17 PICO questions Scientific Committee
  • 8. Outline 1. Patient Blood Management: 3 topics of interest and 17 PICO questions 2.Using a formal consensus methodology: the Consensus Development Conference 3. Using an evidence-based methodology: the GRADE approach
  • 9. 2-day International Consensus Conference on Patient Blood Management (24 & 25 April, Frankfurt, Germany) - 200 medical experts - From 5 continents - Representing more than 10 disciplines (e.g. transfusion medicine, surgery, anesthesiology and haematology) - Co-sponsors: AABB, ISBT, DGTI, SFTS, SIMTI, EBA - Participation: ARCBS, TBS, ICTMG, ISTH, NBA, ÖGBT, SFAR - Presence: WHO, EU Commission, DGAI, National Health Authority Australia
  • 11. Consensus Development Conference (CDC) *Nair R et al., Semin Arthritis Rheum, 2011; Sher G and Devine D, Transfusion, 2007 Major steps in the Consensus Development Conference format? 1) Evidence presented by the SCIENTIFIC COMMITTEE to the conference, CHAIRED in a public (open) session followed by discussion (AUDIENCE) 2) Private (executive) session by DECISION-MAKING panel to further deliberate on the evidence and discussion to reach consensus -> result: draft consensus statement. 3) Presentation of draft consensus statement in a plenary session + review/comment/indicative voting by conference attendees. 4) Final executive session with final consensus statement by DECISION- MAKING PANEL.
  • 12. Outline 1. Patient Blood Management: 3 topics of interest and 17 PICO questions 2. Using a formal consensus methodology: the Consensus Development Conference 3.Using an evidence-based methodology: the GRADE approach
  • 13. GRADE approach From evidence to recommendations – transparent and sensible P I C O Outcome Outcome Outcome Outcome Critical Critical Important Not High Moderate Low Very low GradedownGradeup 1. Risk of bias 2. Inconsistency 3. Indirectness 4. Imprecision 5. Publication bias 1. Large effect 2. Dose response 3. Confounders Summary of findings & estimate of effect for each outcome Systematic review Randomization Experimental: High Observational: Low Scientific Committee
  • 14. GRADE overall quality of the evidence across outcomes based on lowest quality of critical outcomes Guideline development GRADE recommendations Evidence to recommendation • For or against (direction) ↑↓ • Strong or conditional/weak (strength) By considering balance of consequences (evidence to recommendation)  Quality of evidence  Balance benefits/harms  Values and preferences  Resource use (cost(-effectiveness)  Equity – Acceptability - Feasibility • “We recommend using…” • “We recommend against using…” • “We suggest using…” • “We suggest against using…” EtD framework GRADEpro Guideline Formulate recommendations Transparency, clear, actionable Research? Decision-making panelists Audience Rapporteurs (Co-)chairs Panelists GRADE approach From evidence to recommendations – transparent and sensible
  • 15.
  • 16. CRITERIA JUDGEMENT RESEARCH EVIDENCE ADDITIONAL CONSIDERATIONS 1. DESIRABLE EFFECTS How substantial are the desirable anticipated effects? 2. UNDESIRABLE EFFECTS How substantial are the undesirable anticipated effects? 3. CERTAINTY OF EVIDENCE What is the overall quality of the evidence of effects? 4. VALUES Is there important uncertainty about or variability in how much people value the critical outcomes? 5. BALANCE OF EFFECTS Does the balance between desirable and undesirable effects favor the intervention or the comparison? 6. RESOURCES REQUIRED How large are the resource requirements (costs)? 7. COST EFFECTIVENESS Does the cost-effectiveness of the intervention favor the intervention or the comparison? 8. EQUITY What would be the impact on health equity? 9. ACCEPTABILITY Is the intervention acceptable to key stakeholders? 10. FEASIBILITY Is the intervention feasible to implement? Evidence-to-Decision framework Rapporteurs Rapporteurs Rapporteurs Rapporteurs Rapporteurs Rapporteurs Rapporteurs Rapporteurs Rapporteurs Rapporteurs Audience Audience Audience Audience Audience Audience Audience Audience Audience Audience
  • 17. Outline 1. Patient Blood Management: 3 topics of interest and 17 PICO questions 2.Using a formal consensus methodology: the Consensus Development Conference 3.Using an evidence-based methodology: the GRADE approach +
  • 18. 1 year of preparation • Feb 2017: SciCom meeting, Frankfurt (Germany) • June 2017: Sponsors meeting, ISBT Copenhagen (Denmark) • March 2017 – April 2018: 12 SciCom teleconferences • Jan/Feb 2018: two face-to-face meetings with SciSec and chairs, Frankfurt (Germany) • March 2017 – January 2018: systematic reviews 17 PICO questions (+/- 18.000 references screened, 145 studies included) • Dec 2017 – April 2018: • 2 SciCom webinars • 4 panellists webinars • 3 chairs webinars • 1 webinar rapporteurs • 1 tutorial rapporteurs • 2 speakers webinars
  • 19. Start day 1 (24 April 2018)
  • 20. 3 Parallel sessions Session 1: Preoperative anaemia  Definition and diagnosis (PICO 1 and PICO 2)  Treatment (PICO 3) Session 2: RBC transfusion triggers  Intensive care and acute interventions (PICO 4-9 & PICO 14)  Haematology and oncology (PICO 10 & PICO 11)  Neurology (PICO 12 & PICO 13) Session 3: PBM implementation  Effectiveness implementation of ‘comprehensive’ PBM programs (PICO 15)  Effectiveness behavioural interventions (PICO 16)  Effectiveness decision support systems (PICO 17) Day 1 (24 April 2018) Part 1: Plenary • Evidence presented by • Based on Evidence-to-Decision (EtD) framework • Discussion with moderated by • Notes recorded by AudienceRapporteurs (Co-)chairs Panelists Speakers
  • 21. Day 1: 3 parallel/open sessions
  • 22. Day 1: 3 parallel/open sessions
  • 23. 3 Parallel sessions Session 1: Preoperative anaemia  Definition and diagnosis (PICO 1 and PICO 2)  Treatment (PICO 3) Session 2: RBC transfusion triggers  Intensive care and acute interventions (PICO 4-9 & PICO 14)  Haematology and oncology (PICO 10 & PICO 11)  Neurology (PICO 12 & PICO 13) Session 3: PBM implementation  Effectiveness implementation of ‘comprehensive’ PBM programs (PICO 15)  Effectiveness behavioural interventions (PICO 16)  Effectiveness decision support systems (PICO 17) Day 1 (24 April 2018) + + + Part 1: Plenary Part 2: Closed (private/executive session) • Evidence presented by • Based on Evidence-to-Decision (EtD) framework • Discussion with moderated by • Notes recorded by • Based on EtD framework • Draft recommendations by • Moderated by • Notes recorded by AudienceRapporteurs (Co-)chairs Panelists Speakers
  • 24. Day 1: closed session with decision-making panels
  • 25. Draft conclusions at the end of day 1 TYPE OF RECOMMENDATION Strong recommendation against the intervention Conditional recommendation against the intervention Conditional recommendation for either the intervention or the comparison Conditional recommendation for the intervention Strong recommendation for the intervention RECOMMENDATION Option 1: Formulation of a strong or conditional recommendation Terminology strong recommendation: “we recommend…” – “clinicians should…” – “clinicians shoud not….” – “Do….” – “Don’t…..” Terminology weak/conditional recommendation: “we suggest…” – “clinicians might….” – “we conditionally recommend…” Option 2: No recommendation Option 3: Research recommendation JUSTIFICATION … SUBGROUP CONSIDERATIONS … IMPLEMENTATION CONSIDERATIONS … MONITORING AND EVALUATION … RESEARCH PRIORITIES … Closed session with chairs/decision-making panels/rapporteurs
  • 26.  Plenary session with the general audience (all 3 topics)  Presentation draft recommendations/justifications by AudienceRapporteurs (Co-)chairs Panelists Day 2 (25 April 2018)
  • 27.  Plenary session with the general audience (all 3 topics)  Presentation draft recommendations/justifications by  Discussion with/indicative voting by , moderated by the  Notes recorded by AudienceRapporteurs (Co-)chairs Panelists Day 2 (25 April 2018)
  • 28.  Plenary session with the general audience (all 3 topics)  Presentation draft recommendations/justifications by  Discussion with/indicative voting by , moderated by the  Notes recorded by  Closed sessions with the decision-making panelists and (co-) chairs  Formulation of final recommendations by , moderated by the AudienceRapporteurs (Co-)chairs Panelists Day 2 (25 April 2018)
  • 29. Day 2: closed session with decision-making panels
  • 30. Conclusions: 10 evidence-based recommendations  Topic 1: Preoperative anaemia  4 recommendations (1 strong, 3 conditional)  Topic 2: RBC transfusion triggers  4 recommendations (2 strong, 2 conditional)  Topic 3: PBM implementation  2 recommendations (2 conditional)  Research recommendations for all topics
  • 31. Lessons learned to improve a future guideline project  Preparation: time versus resources  2 face-to-face meetings between methodologists and experts  Beginning: PICO + selection criteria (lumping vs splitting!)  Intermediate: to discuss results systematic review  Improve sense of ownership and knowledge of evidence-based methodology by different groups (panel members, chairs)  More rigorous process to select panel members (COI!) and formal/blind voting system on draft/final recommendations  Organization Consensus conference immediately before/after blood transfusion conference (e.g. ISBT) could increase participation (by general audience).
  • 32. Acknowledgments Prof. Dr. Erhard Seifried (German Red Cross Blood Transfusion Services/EBA) (chair) Dr. Kari Aranko (European Blood Alliance/EBA) Willemijn Kramer (European Blood Alliance/EBA) Dr. Markus Müller (Institute for Transfusion Medicine and Immunohaematology Frankfurt/EBA) Prof. Dr. Patrick Meybohm (University Clinics of the Johann Wolfgang Goethe University Frankfurt/Main) Chairs of the Plenary Sessions: Prof. Dr. Reinhard Burger, Robert-Koch-Institute, Berlin, Germany Prof. Dr. Klaus Cichutek, Paul-Ehrlich-Institute, Langen, Germany Prof. Dr. Jimmy Volmink, Faculty of Medicine and Health Sciences at Stellenbosch University, South Africa Decision-making panel ‘Preoperative anaemia’ Prof. Dr. Yves Ozier, University Hospital of Brest, France (Chair) Prof Dr. Emmy De Buck, Centre for Evidence Based Practice, Belgian Red Cross-Flanders, Belgium (Co-Chair) Decision-making panel ‘RBC transfusion triggers’ Prof. Dr. Reinhard Burger, Robert-Koch-Institute, Berlin, Germany (Chair) Prof. Dr. Jimmy Volmink, Faculty of Medicine and Health Sciences at Stellenbosch University, South Africa (Co-Chair) Decision-making panel ‘PBM implementation’ Prof. Dr. Jonathan Waters, Magee-Womens Hospital of the University of Pittsburgh Medical Center (Chair) Prof. Dr. Dean Fergusson, Ottawa Hospital Research Institute, University of Ottawa, Canada (Co-Chair) Stefan Holtzem (Photographer)
  • 33. Acknowledgments Centre for Evidence-Based Practice (CEBaP) Belgian Red Cross www.cebap.org @CEBaP_evidence